Psoriasis: Can Gut Biotics Improve Treatment? Luis Quevedo

https://www.medscape.com/viewarticle/psoriasis-can-gut-biotics-improve-treatment-2026a1000mha?ecd=WNL_trdalrt_pos1_ous_260703_etid8475286&uac=148436CN&impID=8475286 Psoriasis is a chronic immune-mediated inflammatory skin disease that affects approximately 2% of the global population, or an estimated 40-160 million individuals, with about 4 million new cases diagnosed annually. Although the precise cause remains unclear, researchers believe that genetic susceptibility, systemic inflammation, and gut microbiota dysbiosis all contribute to disease development.